Pacific Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacific Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.17 | $-0.22 | 22.7 % |
Jun 2024 | 2024-08-07 | $-0.20 | $-0.23 | 13.0 % |
Mar 2024 | 2024-05-09 | $-0.26 | $-0.27 | 3.70 % |
Dec 2023 | 2024-02-15 | $-0.27 | $-0.28 | 3.57 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $39.97M | $41.96M | -4.75 % |
Jun 2024 | 2024-08-07 | $36.01M | $41.03M | -12.2 % |
Mar 2024 | 2024-05-09 | $38.81M | $42.96M | -9.66 % |
Dec 2023 | 2024-02-15 | $58.36M | $57.49M | 1.51 % |
Pacific Biosciences (PACB) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.17, which beat the estimate of $-0.22.
The Actual Revenue was $40M, which missed the estimate of $42M.
Browse earnings estimates, EPS, and revenue on all stocks.